Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania. Show more

Location: Four Tower Bridge, West Conshohocken, PA, 19428, United States | Website: https://www.madrigalpharma.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

6.665B

52 Wk Range

$200.63 - $377.46

Previous Close

$300.16

Open

$299.52

Volume

340,923

Day Range

$295.43 - $311.21

Enterprise Value

5.996B

Cash

843.1M

Avg Qtr Burn

-98.83M

Insider Ownership

7.73%

Institutional Own.

-

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.